Further, transgenic mice with continuous activation of HRAS gene developed non-invasive bladder cancer, whereas transgenic mice with UPII promoter-SV40T gene in combination with persistent inactivation of p53 and pRb gene developed invasive bladder cancer [15]. This evidence concerns the gene TP53 and urinary bladder cancer.